# Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Source: https://onco.cc/trials/nct07386704/  
OnCo record `nct07386704` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of nimotuzumab in pancreatic cancer, run by Peking University First Hospital, now recruiting.

## Summary

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT07386704 by Peking University First Hospital, with a registry enrolment figure of 30 participants, started 2025-12-09 and due to reach its primary completion in 2026-12-09. Interventions recorded: Nimotuzumab combined with chemoradiotherapy. Conditions listed: Pancreatic Cancer Non-resectable. Primary outcome: LCR. Pancreatic eligibility wording from the registry: "Confirmed by histological or cytological examination as pancreatic adenocarcinoma;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07386704
- Phase: 2
- Setting: A Prospective, Single-arm Study of Nimotuzumab Combined With Radiotherapy and Chemotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
- Sponsor: Peking University First Hospital
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT07386704: https://clinicaltrials.gov/study/NCT07386704

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- drugs: [Nimotuzumab](https://onco.cc/drugs/nimotuzumab/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07386704.json